Abstract
Depression is a serious and frequent comorbidity of epilepsy and other neurological conditions. Here, we review recent studies on the relationship between epilepsy and depression with regard to diagnostic criteria, epidemiology, etiology and treatment. Depression in epilepsy can be described in the general framework of the diathesis–stress model: chronic stress exposure owing to the 'burden of epilepsy' and learned helplessness due to the threat of recurrent seizures as unpredictable aversive events represent psychological risk factors for the development of depression. Epilepsy-related factors (for example, focus site or side) have shown little effect on mood. Nonepileptic individuals who are adversely affected by seizures (for example, parents of pediatric patients with epilepsy, and patients with psychogenic nonepileptic seizures) show increased levels of depression, similar to patients with epilepsy. However, seizures, subclinical hypersynchronous neural discharges and some antiepileptic drugs may cause acute states of depressive mood or depression on a purely neurobiological basis. Antidepressant drugs and psychotherapy have shown moderate efficacy in the treatment of depression comorbidity, but randomized controlled trials in patients with epilepsy are lacking, especially for drugs.
Key Points
-
Depression is a frequent comorbidity of epilepsy
-
Depression comorbidity in epilepsy can be explained in the framework of the diathesis–stress model
-
Seizures, subclinical hypersynchronous neural discharges and some antiepileptic drugs may cause acute states of depressive mood on a purely neurobiological basis
-
Nonepileptic individuals who are adversely affected by seizures (for example, parents of pediatric patients, and patients with psychogenic seizures) show elevated levels of depression, similar to patients with epilepsy
-
Antidepressants and psychotherapy seem to have a comparable, moderate antidepressant effect, but randomized controlled trials are lacking, particularly for drugs
-
More-comprehensive approaches to the understanding and treatment of depression and suicidality in epilepsy, which combine drug treatment with psychotherapy and rehabilitative care, need to be developed
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Marcus, S. C. & Olfson, M. National trends in the treatment for depression from 1998 to 2007. Arch. Gen. Psychiatry 67, 1265–1273 (2010).
Kanner, A. M., Barry, J. J., Gilliam, F., Hermann, B. & Meador, K. J. Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy? Epilepsia 51, 1152–1158 (2010).
Global Parkinson's Disease Survey Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov. Disord. 17, 60–67 (2002).
Lule, D. et al. Life can be worth living in locked-in syndrome. Prog. Brain Res. 177, 339–351 (2009).
Pena, P., Sancho, J., Rufo, M., Martinez, S. & Rejas, J. Driving cost factors in adult outpatients with refractory epilepsy: a daily clinical practice in clinics of neurology in Spain. Epilepsy Res. 83, 133–143 (2009).
Reynolds, E. H. & Trimble, M. R. Epilepsy, psychiatry, and neurology. Epilepsia 50 (Suppl. 3), 50–55 (2009).
Barry, J. J. et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav. 13, S1–S29 (2008).
Hermann, B., Seidenberg, M. & Jones, J. The neurobehavioural comorbidities of epilepsy: can a natural history be developed? Lancet Neurol. 7, 151–160 (2008).
LaFrance, W. C. Jr, Kanner, A. M. & Hermann, B. Psychiatric comorbidities in epilepsy. Int. Rev. Neurobiol. 83, 347–383 (2008).
Mula, M., Schmitz, B. & Sander, J. W. The pharmacological treatment of depression in adults with epilepsy. Expert Opin. Pharmacother. 9, 3159–3168 (2008).
de Boer, H. M., Mula, M. & Sander, J. W. The global burden and stigma of epilepsy. Epilepsy Behav. 12, 540–546 (2008).
Verrotti, A. et al. Epilepsy and suicide: pathogenesis, risk factors, and prevention. Neuropsychiatr. Dis. Treat. 4, 365–370 (2008).
Meador, K. J. Suicide in patients with epilepsy. Epilepsy Curr. 8, 40–42 (2008).
Kanner, A. M. Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav. 15, 83–87 (2009).
Beyenburg, S., Mitchell, A. J., Schmidt, D., Elger, C. E. & Reuber, M. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav. 7, 161–171 (2005).
Kanner, A. Depression and epilepsy: A bidirectional relation? Epilepsia 52 (Suppl. 1), 21–27 (2011).
Feinstein, A. R. The pre-therapeutic classification of co-morbidity in chronic disease. J. Chronic Dis. 23, 455–468 (1970).
Zimmermann, F. & Endermann, M. Self-proxy agreement and correlates of health-related quality of life in young adults with epilepsy and mild intellectual disabilities. Epilepsy Behav. 13, 202–211 (2008).
Canuet, L. et al. Factors associated with impaired quality of life in younger and older adults with epilepsy. Epilepsy Res. 83, 58–65 (2009).
Hall, K. E., Isaac, C. L. & Harris, P. Memory complaints in epilepsy: An accurate reflection of memory impairment or an indicator of poor adjustment? A review of the literature. Clin. Psychol. Rev. 29, 354–367 (2009).
Liik, M., Vahter, L., Gross-Paju, K. & Haldre, S. Subjective complaints compared to the results of neuropsychological assessment in patients with epilepsy: the influence of comorbid depression. Epilepsy Res. 84, 194–200 (2009).
Pompili, M. et al. Depression, hopelessness and suicide risk among patients suffering from epilepsy. Ann. Ist. Super. Sanita 43, 425–429 (2007).
Beck, A. T., Brown, G., Berchick, R. J., Stewart, B. L. & Steer, R. A. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am. J. Psychiatry 147, 190–195 (1990).
Mula, M. et al. Interictal dysphoric disorder and periictal dysphoric symptoms in patients with epilepsy. Epilepsia 51, 1139–1145 (2010).
Krishnamoorthy, E. S., Trimble, M. R. & Blumer, D. The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy. Epilepsy Behav. 10, 349–353 (2007).
Valderas, J. M., Starfield, B., Sibbald, B., Salisbury, C. & Roland, M. Defining comorbidity: implications for understanding health and health services. Ann. Fam. Med. 7, 357–363 (2009).
Jensen, F. E. Epilepsy as a spectrum disorder: implications from novel clinical and basic neuroscience. Epilepsia 52 (Suppl. 1), 1–6 (2011).
Fuller-Thomson, E. & Brennenstuhl, S. The association between depression and epilepsy in a nationally representative sample. Epilepsia 50, 1051–1058 (2009).
Villanueva, V. et al. Validation of the Spanish version of the Side Effect and Life Satisfaction Inventory in patients with epilepsy. Epilepsy Behav. 14, 96–101 (2009).
Mensah, S. A., Beavis, J. M., Thapar, A. K. & Kerr, M. P. A community study of the presence of anxiety disorder in people with epilepsy. Epilepsy Behav. 11, 118–124 (2007).
Mensah, S. A., Beavis, J. M., Thapar, A. K. & Kerr, M. The presence and clinical implications of depression in a community population of adults with epilepsy. Epilepsy Behav. 8, 213–219 (2006).
de Oliveira, G. N. et al. Brazilian version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). Epilepsy Behav. 19, 328–331 (2010).
Stefanello, S., Marin-Leon, L., Fernandes, P. T., Li, L. M. & Botega, N. J. Psychiatric comorbidity and suicidal behavior in epilepsy: a community-based case–control study. Epilepsia 51, 1120–1125 (2010).
Devinsky, O. et al. Changes in depression and anxiety after resective surgery for epilepsy. Neurology 65, 1744–1749 (2005).
Friedman, D. E. et al. Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening. Seizure 18, 429–433 (2009).
Desai, S. D. et al. Study of DSM-IV Axis I psychiatric disorders in patients with refractory complex partial seizures using a short structured clinical interview. Epilepsy Behav. 19, 301–305 (2010).
Ekinci, O., Titus, J. B., Rodopman, A. A., Berkem, M. & Trevathan, E. Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment. Epilepsy Behav. 14, 8–18 (2009).
Fortin, M., Hudon, C., Haggerty, J., Akker, M. & Almirall, J. Prevalence estimates of multimorbidity: a comparative study of two sources. BMC Health Serv. Res. 10, 111 (2010).
Mula, M. et al. On the prevalence of bipolar disorder in epilepsy. Epilepsy Behav. 13, 658–661 (2008).
Adams, S. J. et al. Neuropsychiatric morbidity in focal epilepsy. Br. J. Psychiatry 192, 464–469 (2008).
Baker, G. A. Depression and suicide in adolescents with epilepsy. Neurology 66, S5–S12 (2006).
Bell, G. S. & Sander, J. W. Suicide and epilepsy. Curr. Opin. Neurol. 22, 174–178 (2009).
Stefanello, S., Marin-Leon, L., Fernandes, P. T., Min, L. L. & Botega, N. J. Suicidal thoughts in epilepsy: a community-based study in Brazil. Epilepsy Behav. 17, 483–488 (2010).
Fu, C. W. et al. The prevalence of anxiety symptoms and depressive symptoms in patients with somatic disorders in urban China: a multi-center cross-sectional study. Int. J. Psychiatry Med. 37, 185–199 (2007).
Reijnders, J. S., Ehrt, U., Weber, W. E., Aarsland, D. & Leentjens, A. F. A systematic review of prevalence studies of depression in Parkinson's disease. Mov. Disord. 23, 183–189 (2008).
Blumer, D., Montouris, G. & Davies, K. The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. Epilepsy Behav. 5, 826–840 (2004).
Mula, M. et al. Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. Epilepsia 49, 650–656 (2008).
Ferguson, P. L. et al. A population-based study of risk of epilepsy after hospitalization for traumatic brain injury. Epilepsia 51, 891–898 (2010).
Kharatishvili, I. & Pitkanen, A. Posttraumatic epilepsy. Curr. Opin. Neurol. 23, 183–188 (2010).
Ettinger, A. B., Copeland, L. A., Zeber, J. E., Van Cott, A. C. & Pugh, M. J. V. Are psychiatric disorders independent risk factors for new-onset epilepsy in older individuals? Epilepsy Behav. 17, 70–74 (2010).
McLaughlin, D. P., Pachana, N. A. & McFarland, K. Depression in a community-dwelling sample of older adults with late-onset or lifetime epilepsy. Epilepsy Behav. 12, 281–285 (2008).
Dickens, C. et al. New onset depression following myocardial infarction predicts cardiac mortality. Psychosom. Med. 70, 450–455 (2008).
Pan, A. et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch. Intern. Med. 170, 1884–1891 (2010).
Menza, M. et al. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 72, 886–892 (2009).
Strodl, E. & Kenardy, J. The 5-item mental health index predicts the initial diagnosis of nonfatal stroke in older women. J. Womens Health (Larchmt) 17, 979–986 (2008).
Devanand, D. P. et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch. Gen. Psychiatry 53, 175–182 (1996).
Hermann, B. P., Trenerry, M. R. & Colligan, R. C. Learned helplessness, attributional style, and depression in epilepsy. Bozeman Epilepsy Surgery Consortium. Epilepsia 37, 680–686 (1996).
Wagner, J. L., Smith, G., Ferguson, P. L., Horton, S. & Wilson, E. A hopelessness model of depressive symptoms in youth with epilepsy. J. Pediatr. Psychol. 34, 89–96 (2009).
McLaughlin, D. P., Pachana, N. A. & McFarland, K. The impact of depression, seizure variables and locus of control on health related quality of life in a community dwelling sample of older adults. Seizure 19, 232–236 (2010).
Asadi-Pooya, A. A., Schilling, C. A., Glosser, D., Tracy, J. I. & Sperling, M. R. Health locus of control in patients with epilepsy and its relationship to anxiety, depression, and seizure control. Epilepsy Behav. 11, 347–350 (2007).
McEwen, B. S. & Stellar, E. Stress and the individual. Mechanisms leading to disease. Arch. Intern. Med. 153, 2093–2101 (1993).
McEwen, B. S. Stress, adaptation, and disease. Allostasis and allostatic load. Ann. NY Acad. Sci. 840, 33–44 (1998).
Friedman, D. E. & Gilliam, F. G. Seizure-related injuries are underreported in pharmacoresistant localization-related epilepsy. Epilepsia 51, 43–47 (2010).
Hamelin, S., Kahane, P. & Vercueil, L. Fatigue in epilepsy: a prospective inter-ictal and post-ictal survey. Epilepsy Res. 91, 153–160 (2010).
Hesdorffer, D. C. & Lee, P. Health, wealth, and culture as predominant factors in psychosocial morbidity. Epilepsy Behav. 15, S36–S40 (2009).
Thompson, A. W., Miller, J. W., Katon, W., Chaytor, N. & Ciechanowski, P. Sociodemographic and clinical factors associated with depression in epilepsy. Epilepsy Behav. 14, 655–660 (2009).
Whatley, A. D., DiIorio, C. K. & Yeager, K. Examining the relationships of depressive symptoms, stigma, social support and regimen-specific support on quality of life in adult patients with epilepsy. Health Educ. Res. 25, 575–584 (2010).
Lee, S. A., Lee, S. M. & No, Y. J. Factors contributing to depression in patients with epilepsy. Epilepsia 51, 1305–1308 (2010).
Kwan, P., Yu, E., Leung, H., Leon, T. & Mychaskiw, M. A. Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy. Epilepsia 50, 1059–1066 (2009).
Lacey, C. J., Salzberg, M. R., Roberts, H., Trauer, T. & D'Souza, W. J. Psychiatric comorbidity and impact on health service utilization in a community sample of patients with epilepsy. Epilepsia 50, 1991–1994 (2009).
Winkler, A. S. et al. Belief systems of epilepsy and attitudes toward people living with epilepsy in a rural community of northern Tanzania. Epilepsy Behav. 19, 596–601 (2010).
Mecarelli, O. et al. Past and present public knowledge and attitudes toward epilepsy in Italy. Epilepsy Behav. 18, 110–115 (2010).
Danielsson, S. et al. Psychopathology, psychosocial functioning, and IQ before and after epilepsy surgery in children with drug-resistant epilepsy. Epilepsy Behav. 14, 330–337 (2009).
Siegel, A. M., Cascino, G. D., Fessler, A. J., So, E. L. & Meyer, F. B. Psychiatric co-morbidity in 75 patients undergoing epilepsy surgery: lack of correlation with pathological findings. Epilepsy Res. 80, 158–162 (2008).
Wilson, S. J., Wrench, J. M., McIntosh, A. M., Bladin, P. F. & Berkovic, S. F. Profiles of psychosocial outcome after epilepsy surgery: the role of personality. Epilepsia 51, 1133–1138 (2010).
Reisinger, E. L. & Dilorio, C. Individual, seizure-related, and psychosocial predictors of depressive symptoms among people with epilepsy over six months. Epilepsy Behav. 15, 196–201 (2009).
Austin, J. K. et al. Self-esteem and symptoms of depression in children with seizures: relationships with neuropsychological functioning and family variables over time. Epilepsia 51, 2074–2083 (2010).
Taylor, J. et al. Factors predictive of resilience and vulnerability in new-onset epilepsy. Epilepsia 52, 610–618 (2010).
Kopp, C. M. C., Muzykewicz, D. D. A., Staley, B. A., Thiele, E. A. & Pulsifer, M. B. Behavior problems in children with tuberous sclerosis complex and parental stress. Epilepsy Behav. 13, 505–510 (2008).
Wood, L. J., Sherman, E. M. S., Hamiwka, L. D., Blackman, M. A. & Wirrell, E. C. Maternal depression: the cost of caring for a child with intractable epilepsy. Pediatr. Neurol. 39, 418–422 (2008).
Ferro, M. A. & Speechley, K. N. Depressive symptoms among mothers of children with epilepsy: a review of prevalence, associated factors, and impact on children. Epilepsia 50, 2344–2354 (2009).
Ferro, M. A., Avison, W. R., Campbell, M. K. & Speechley, K. N. Prevalence and trajectories of depressive symptoms in mothers of children with newly diagnosed epilepsy. Epilepsia 52, 326–336 (2011).
Chiou, H. H. & Hsieh, L. P. Parenting stress in parents of children with epilepsy and asthma. J. Child Neurol. 23, 301–306 (2008).
Cushner-Weinstein, S. et al. Parenting stress and childhood epilepsy: the impact of depression, learning, and seizure-related factors. Epilepsy Behav. 13, 109–114 (2008).
Shore, C. P., Austin, J. K. & Dunn, D. W. Maternal adaptation to a child's epilepsy. Epilepsy Behav. 5, 557–568 (2004).
Marchetti, R. L. et al. Psychiatric diagnoses of patients with psychogenic non-epileptic seizures. Seizure 17, 247–253 (2008).
Schramke, C. J., Kay, K. A., Valeriano, J. P. & Kelly, K. M. Using patient history to distinguish between patients with non-epileptic and patients with epileptic events. Epilepsy Behav. 19, 478–482 (2010).
Koby, D. G. et al. Questioning the role of abuse in behavioral spells and epilepsy. Epilepsy Behav. 19, 584–590 (2010).
Sperling, M. R., Schilling, C. A., Glosser, D., Tracy, J. I. & Asadi-Pooya, A. A. Self-perception of seizure precipitants and their relation to anxiety level, depression, and health locus of control in epilepsy. Seizure 17, 302–307 (2008).
Kanner, A. M., Trimble, M. & Schmitz, B. Postictal affective episodes. Epilepsy Behav. 19, 156–158 (2010).
Nishida, T. et al. Postictal mania versus postictal psychosis: differences in clinical features, epileptogenic zone, and brain functional changes during postictal period. Epilepsia 47, 2104–2114 (2006).
Fincham, R. & Anderson, S. Postictal depression following subtle seizures. Epilepsy Behav. 1, 278–280 (2000).
Hoppe, C., Poepel, A. & Elger, C. E. Epilepsy: accuracy of patient seizure counts. Arch. Neurol. 64, 1595–1599 (2007).
Blumer, D. Postictal depression: significance for the treatment of the neurobehavioral disorder of epilepsy. J. Epilepsy 5, 214–219 (1992).
Garcia-Morales, I., Mayor, P. D. & Kanner, A. M. Psychiatric comorbidities in epilepsy: identification and treatment. Neurologist 14, S15–S25 (2008).
Volkl-Kernstock, S., Bauch-Prater, S., Ponocny-Seliger, E. & Feucht, M. Speech and school performance in children with benign partial epilepsy with centro-temporal spikes (BCECTS). Seizure 18, 320–326 (2009).
Hessen, E., Lossius, M. I. & Gjerstad, L. Behavioural adjustment in seizure-free epilepsy patients on monotherapy. Seizure 17, 422–430 (2008).
Micallef, S., Spooner, C. G., Harvey, A. S., Wrennall, J. A. & Wilson, S. J. Psychological outcome profiles in childhood-onset temporal lobe epilepsy. Epilepsia 51, 2066–2073 (2010).
Witt, J. A., Hollmann, K. & Helmstaedter, C. The impact of lesions and epilepsy on personality and mood in patients with symptomatic epilepsy: a pre- to postoperative follow-up study. Epilepsy Res. 82, 139–146 (2008).
Dias, R. et al. Depression in epilepsy is associated with lack of seizure control. Epilepsy Behav. 19, 445–447 (2010).
Seminario, N. A., Farias, S. T., Jorgensen, J., Bourgeois, J. A. & Seyal, M. Determination of prevalence of depression in an epilepsy clinic using a brief DSM-IV-based self-report questionnaire. Epilepsy Behav. 15, 362–366 (2009).
Bell, G. S., Gaitatzis, A., Bell, C. L., Johnson, A. L. & Sander, J. W. Suicide in people with epilepsy: how great is the risk? Epilepsia 50, 1933–1942 (2009).
Kanner, A. M., Byrne, R., Chicharro, A., Wuu, J. & Frey, M. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology 72, 793–799 (2009).
Metternich, B. et al. Preoperative depressive symptoms predict postoperative seizure outcome in temporal and frontal lobe epilepsy. Epilepsy Behav. 16, 622–628 (2009).
Thapar, A., Kerr, M. & Harold, G. Stress, anxiety, depression, and epilepsy: investigating the relationship between psychological factors and seizures. Epilepsy Behav. 14, 134–140 (2009).
Guarnieri, R. et al. Do psychiatric comorbidities predict postoperative seizure outcome in temporal lobe epilepsy surgery? Epilepsy Behav. 14, 529–534 (2009).
Hughes, J. R. Periodic lateralized epileptiform discharges: do they represent an ictal pattern requiring treatment? Epilepsy Behav. 18, 162–165 (2010).
Shelley, B. P., Trimble, M. R. & Boutros, N. N. Electroencephalographic cerebral dysrhythmic abnormalities in the trinity of nonepileptic general population, neuropsychiatric, and neurobehavioral disorders. J. Neuropsychiatry Clin. Neurosci. 20, 7–22 (2008).
Vaaler, A. E. et al. Symptoms of epilepsy and organic brain dysfunctions in patients with acute, brief depression combined with other fluctuating psychiatric symptoms: a controlled study from an acute psychiatric department. BMC Psychiatry 9, 63 (2009).
Vaaler, A. E., Morken, G., Iversen, V. C., Kondziella, D. & Linaker, O. M. Acute unstable depressive syndrome (AUDS) is associated more frequently with epilepsy than major depression. BMC Neurol. 10, 67 (2010).
Mula, M. & Monaco, F. Antiepileptic drugs and psychopathology of epilepsy: an update. Epilept. Disord. 11, 1–9 (2009).
Miller, J. M., Kustra, R. P., Vuong, A., Hammer, A. E. & Messenheimer, J. A. Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs. Drugs 68, 1493–1509 (2008).
Arana, A., Wentworth, C. E., Ayuso-Mateos, J. L. & Arellano, F. M. Suicide-related events in patients treated with antiepileptic drugs. N. Engl. J. Med. 363, 542–551 (2010).
VanCott, A. C. et al. Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med. 8, 4 (2010).
Olesen, J. B. et al. Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol. Drug Saf. 19, 518–524 (2010).
Hesdorffer, D. C. & Kanner, A. M. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia 50, 978–986 (2009).
Shneker, B. F., Cios, J. S. & Elliott, J. O. Suicidality, depression screening, and antiepileptic drugs: reaction to the FDA alert. Neurology 72, 987–991 (2009).
Ketter, T. A., Post, R. M. & Theodore, W. H. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 53, S53–S67 (1999).
Elger, C. E. & Schmidt, D. Modern management of epilepsy: a practical approach. Epilepsy Behav. 12, 501–539 (2008).
Brent, D. A., Crumrine, P. K., Varma, R. R., Allan, M. & Allman, C. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 80, 909–917 (1987).
Brent, D. A., Crumrine, P. K., Varma, R., Brown, R. V. & Allan, M. J. Phenobarbital treatment and major depressive disorder in children with epilepsy: a naturalistic follow-up. Pediatrics 85, 1086–1091 (1990).
Lopez-Gomez, M. et al. Primidone is associated with interictal depression in patients with epilepsy. Epilepsy Behav. 6, 413–416 (2005).
Fakhoury, T. A., Miller, J. M., Hammer, A. E. & Vuong, A. Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study. Drugs Aging 25, 955–962 (2008).
Labiner, D. M. et al. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. Epilepsia 50, 434–442 (2009).
Mazza, M., Martini, A., Scoppetta, M. & Mazza, S. Effect of levetiracetam on depression and anxiety in adult epileptic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 539–543 (2008).
Helmstaedter, C., Fritz, N., Kockelmann, E., Kosanetzky, N. & Elger, C. Positive and negative psychotropic effects of levetiracetam. Epilepsy Behav. 13, 535–541 (2008).
Mula, M., Trimble, M. R., Yuen, A., Liu, R. S. & Sander, J. W. Psychiatric adverse events during levetiracetam therapy. Neurology 61, 704–706 (2003).
Mula, M., Hesdorffer, D. C., Trimble, M. & Sander, J. W. The role of titration schedule of topiramate for the development of depression in patients with epilepsy. Epilepsia 50, 1072–1076 (2009).
Richy, F. F., Banerjee, S., Brabant, Y. & Helmers, S. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques. Epilepsy Behav. 16, 240–245 (2009).
Wrench, J. M., Wilson, S. J., Bladin, P. F. & Reutens, D. C. Hippocampal volume and depression: insights from epilepsy surgery. J. Neurol. Neurosurg. Psychiatry 80, 539–544 (2009).
Salgado, P. C., Yasuda, C. L. & Cendes, F. Neuroimaging changes in mesial temporal lobe epilepsy are magnified in the presence of depression. Epilepsy Behav. 19, 422–427 (2010).
Shamim, S., Hasler, G., Liew, C., Sato, S. & Theodore, W. H. Temporal lobe epilepsy, depression, and hippocampal volume. Epilepsia 50, 1067–1071 (2009).
van Elst, L. T., Groffmann, M., Ebert, D. & Schulze-Bonhage, A. Amygdala volume loss in patients with dysphoric disorder of epilepsy. Epilepsy Behav. 16, 105–112 (2009).
Caplan, R. et al. Suicidality and brain volumes in pediatric epilepsy. Epilepsy Behav. 18, 286–290 (2010).
Assem-Hilger, E. et al. Central serotonin 1A receptor binding in temporal lobe epilepsy: a [carbonyl-11C]WAY-100635 PET study. Epilepsy Behav. 19, 467–473 (2010).
Lothe, A. et al. Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain 131, 2765–2782 (2008).
Bonelli, S. B. et al. Preoperative amygdala fMRI in temporal lobe epilepsy. Epilepsia 50, 217–227 (2009).
Gilliam, F. G. et al. Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy. Neurology 68, 364–368 (2007).
Babu, C. S., Satishchandra, P., Sinha, S. & Subbakrishna, D. K. Co-morbidities in people living with epilepsy: hospital based case-control study from a resource-poor setting. Epilepsy Res. 86, 146–152 (2009).
de Araujo, G. M. et al. Psychiatric comorbidity in epilepsy: a study comparing patients with mesial temporal sclerosis and juvenile myoclonic epilepsy. Epilepsy Behav. 13, 196–201 (2008).
Asmussen, S. B., Kirlin, K. A., Gale, S. D. & Chung, S. S. Differences in self-reported depressive symptoms between patients with epileptic and psychogenic nonepileptic seizures. Seizure 18, 564–566 (2009).
Rayner, G., Wrench, J. M. & Wilson, S. J. Differential contributions of objective memory and mood to subjective memory complaints in refractory focal epilepsy. Epilepsy Behav. 19, 359–364 (2010).
Ertekin, B. A. et al. A comparative study of obsessive-compulsive disorder and other psychiatric comorbidities in patients with temporal lobe epilepsy and idiopathic generalized epilepsy. Epilepsy Behav. 14, 634–639 (2009).
Sanchez-Gistau, V. et al. Prevalence of interictal psychiatric disorders in patients with refractory temporal and extratemporal lobe epilepsy in Spain. A comparative study. Epilepsia 51, 1309–1313 (2010).
Bragatti, J. A. et al. Left-sided EEG focus and positive psychiatric family history are independent risk factors for affective disorders in temporal lobe epilepsy. Epilepsy Res. 87, 169–176 (2009).
de Oliveira, G. N. M. et al. Psychiatric disorders in temporal lobe epilepsy: an overview from a tertiary service in Brazil. Seizure 19, 479–484 (2010).
Pizzi, A. M., Chapin, J. S., Tesar, G. E. & Busch, R. M. Comparison of personality traits in patients with frontal and temporal lobe epilepsies. Epilepsy Behav. 15, 225–229 (2009).
DeRubeis, R. J., Siegle, G. J. & Hollon, S. D. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat. Rev. Neurosci. 9, 788–796 (2008).
Mor, N. & Haran, D. Cognitivebehavioral therapy for depression. Isr. J. Psychiatry Relat. Sci. 46, 269–273 (2009).
Beltman, M. W., Voshaar, R. C. & Speckens, A. E. Cognitive-behavioural therapy for depression in people with a somatic disease: meta-analysis of randomised controlled trials. Br. J. Psychiatry 197, 11–19 (2010).
Cuijpers, P., Smit, F., Bohlmeijer, E., Hollon, S. D. & Andersson, G. Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias. Br. J. Psychiatry 196, 173–178 (2010).
Pull, C. B. Current empirical status of acceptance and commitment therapy. Curr. Opin. Psychiatry 22, 55–60 (2009).
Forman, E. M., Herbert, J. D., Moitra, E., Yeomans, P. D. & Geller, P. A. A randomized controlled effectiveness trial of acceptance and commitment therapy and cognitive therapy for anxiety and depression. Behav. Modif. 31, 772–799 (2007).
Sturmey, P. Behavioral activation is an evidence-based treatment for depression. Behav. Modif. 33, 818–829 (2009).
Thompson, N. J. et al. Distance delivery of mindfulness-based cognitive therapy for depression: project UPLIFT. Epilepsy Behav. 19, 247–254 (2010).
Walker, E. R., Obolensky, N., Dini, S. & Thompson, N. J. Formative and process evaluations of a cognitive-behavioral therapy and mindfulness intervention for people with epilepsy and depression. Epilepsy Behav. 19, 239–246 (2010).
Ciechanowski, P. et al. PEARLS depression treatment for individuals with epilepsy: a randomized controlled trial. Epilepsy Behav. 19, 225–231 (2010).
Wagner, J. L., Smith, G., Ferguson, P., van Bakergem, K. & Hrisko, S. Pilot study of an integrated cognitive-behavioral and self-management intervention for youth with epilepsy and caregivers: Coping Openly and Personally with Epilepsy (COPE). Epilepsy Behav. 18, 280–285 (2010).
DiIorio, C. et al. Project EASE: a study to test a psychosocial model of epilepsy medication managment. Epilepsy Behav. 5, 926–936 (2004).
Lundgren, T., Dahl, J., Yardi, N. & Melin, L. Acceptance and commitment therapy and yoga for drug-refractory epilepsy: a randomized controlled trial. Epilepsy Behav. 13, 102–108 (2008).
Lundgren, T., Dahl, J. & Hayes, S. C. Evaluation of mediators of change in the treatment of epilepsy with acceptance and commitment therapy. J. Behav. Med. 31, 225–235 (2008).
Martinovic, Z., Simonovic, P. & Djokic, R. Preventing depression in adolescents with epilepsy. Epilepsy Behav. 9, 619–624 (2006).
Kuyk, J., Siffels, M. C., Bakvis, P. & Swinkels, W. A. Psychological treatment of patients with psychogenic non-epileptic seizures: an outcome study. Seizure 17, 595–603 (2008).
LaFrance, W. C. Jr et al. Cognitive behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav. 14, 591–596 (2009).
Arida, R. M., Scorza, F. A. & Cavalheiro, E. A. Favorable effects of physical activity for recovery in temporal lobe epilepsy. Epilepsia 51, 76–79 (2010).
Arida, R. M., Scorza, F. A., da Silva, S. G., Schachter, S. C. & Cavalheiro, E. A. The potential role of physical exercise in the treatment of epilepsy. Epilepsy Behav. 17, 432–435 (2010).
Charyton, C., Elliott, J. O., Moore, J. L. & Klatte, E. T. Is it time to consider cognitive behavioral therapy for persons with epilepsy? Clues from pathophysiology, treatment and functional neuroimaging. Expert Rev. Neurother. 10, 1911–1927 (2010).
Ioannidis, J. P. Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philos. Ethics Humanit. Med. 3, 14 (2008).
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A. & Rosenthal, R. Selective publication of antidepressant trials and its influence on apparent efficacy. N. Engl. J. Med. 358, 252–260 (2008).
Kirsch, I. et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 5, e45 (2008).
Fournier, J. C. et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 303, 47–53 (2010).
Khan, A., Leventhal, R. M., Khan, S. R. & Brown, W. A. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J. Clin. Psychopharmacol. 22, 40–45 (2002).
Bernardo, C. G., Singh, V. & Thompson, P. M. Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders. Expert Opin. Drug Saf. 7, 435–445 (2008).
Cotterman-Hart, S. Depression in epilepsy: why aren't we treating? Epilepsy Behav. 19, 419 (2010).
Robertson, M. M. & Trimble, M. R. The treatment of depression in patients with epilepsy. A double-blind trial. J. Affect Disord. 9, 127–136 (1985).
Specchio, L. M. et al. Citalopram as treatment of depression in patients with epilepsy. Clin. Neuropharmacol. 27, 133–136 (2004).
Kanner, A. M., Kozak, A. M. & Frey, M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav. 1, 100–105 (2000).
Kuhn, K. U. et al. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav. 4, 674–679 (2003).
Thome-Souza, M. S., Kuczynski, E. & Valente, K. D. Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav. 10, 417–425 (2007).
Tosun, A. et al. The effect of depression on academic achievement in children with epilepsy. Epilepsy Behav. 13, 494–498 (2008).
Kondziella, D. & Asztely, F. Don't be afraid to treat depression in patients with epilepsy! Acta Neurol. Scand. 119, 75–80 (2009).
Sandstrom, S. A., Bowman, E. S., Johnson, C. S. & Salanova, V. Interictal mood disorder and quality of life in active epilepsy. Epilepsy Behav. 17, 199–204 (2010).
Gibbons, R. D., Hur, K., Bhaumik, D. K. & Mann, J. J. The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am. J. Psychiatry 163, 1898–1904 (2006).
Gibbons, R. D. et al. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am. J. Psychiatry 164, 1044–1049 (2007).
Libby, A. M., Orton, H. D. & Valuck, R. J. Persisting decline in depression treatment after FDA warnings. Arch. Gen. Psychiatry 66, 633–639 (2009).
Olfson, M. & Marcus, S. C. National patterns in antidepressant medication treatment. Arch. Gen. Psychiatry 66, 848–856 (2009).
Hu, G., Wilcox, H. C., Wissow, L. & Baker, S. P. Mid-life suicide: an increasing problem in US Whites, 1999–2005. Am. J. Prev. Med. 35, 589–593 (2008).
McGlone, J. et al. Quality of life and memory after vagus nerve stimulator implantation for epilepsy. Can. J. Neurol. Sci. 35, 287–296 (2008).
Dodrill, C. B. & Morris, G. L. Effects of vagal nerve stimulation on cognition and quality of life in epilepsy. Epilepsy Behav. 2, 46–53 (2001).
Ridsdale, L. The social causes of inequality in epilepsy and developing a rehabilitation strategy: a UK-based analysis. Epilepsia 50, 2175–2179 (2009).
Brodtkorb, E. & Mula, M. Optimizing therapy of seizures in adult patients with psychiatric comorbidity. Neurology 67, S39–S44 (2006).
Nardi, R. et al. Co-morbidity does not reflect complexity in internal medicine patients. Eur. J. Intern. Med. 18, 359–368 (2007).
Safford, M. M., Allison, J. J. & Kiefe, C. I. Patient complexity: more than comorbidity. The vector model of complexity. J. Gen. Intern. Med. 22 (Suppl. 3), 382–390 (2007).
Wrench, J. M., Wilson, S. J., O'Shea, M. F. & Reutens, D. C. Characterising de novo depression after epilepsy surgery. Epilepsy Res. 83, 81–88 (2009).
Kanner, A. M. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol. Psychiatry 54, 388–398 (2003).
Monroe, S. M. & Simons, A. D. Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychol. Bull. 110, 406–425 (1991).
Diener, H. C. & Putzki, N. Leitlinien fĂĽr Diagnostik und Therapie in der Neurologie (Georg Thieme Verlag, Stuttgart, 2008).
Author information
Authors and Affiliations
Contributions
C. Hoppe researched the data for and wrote the article. C. Hoppe and C. E. Elger contributed equally to discussions of the content and to review and/or editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Hoppe, C., Elger, C. Depression in epilepsy: a critical review from a clinical perspective. Nat Rev Neurol 7, 462–472 (2011). https://doi.org/10.1038/nrneurol.2011.104
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2011.104
This article is cited by
-
Fast–slow variable dissection with two slow variables related to calcium concentrations: a case study to bursting in a neural pacemaker model
Nonlinear Dynamics (2022)
-
Epilepsy Associated Depression: An Update on Current Scenario, Suggested Mechanisms, and Opportunities
Neurochemical Research (2021)
-
Komorbidität Depression bei Epilepsie
Zeitschrift fĂĽr Epileptologie (2018)
-
Design, synthesis, characterization, and molecular modeling studies of novel oxadiazole derivatives of nipecotic acid as potential anticonvulsant and antidepressant agents
Medicinal Chemistry Research (2018)